Ventilation during cardiopulmonary bypass: Impact on neutrophil activation and pulmonary sequestration

Journal of Investigative Surgery

Volumn 22, Issue 5, 2009, Pages 333-339

  Ng, Calvin S H ^a   Wan, Song ^a   Wan, Innes Y P ^a   Hui, Connie W C ^a   Wong, Randolph H L ^a   Ho, Anthony M H ^a   Underwood, Malcolm J ^a  

^a CHINESE UNIVERSITY OF HONG KONG   (Hong Kong)

Author keywords

Cardiopulmonary bypass; CD11b; Neutrophil sequestration; Ventilation

Indexed keywords

CD11B ANTIGEN; CD45 ANTIGEN;

ADULT; AORTA CLAMPING; ARTICLE; CARDIOPULMONARY BYPASS; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CORONARY ARTERY BYPASS GRAFT; FEMALE; FLOW CYTOMETRY; FLUORESCENCE; HUMAN; LEUKOCYTE ACTIVATION; LEUKOCYTE DIFFERENTIAL COUNT; LUNG LAVAGE; LUNG SEQUESTRATION; LUNG VENTILATION; MALE; NEUTROPHIL COUNT; PRIORITY JOURNAL; PROSPECTIVE STUDY; RANDOMIZED CONTROLLED TRIAL;

AGED; ANTIGENS, CD11B; BRONCHOPULMONARY SEQUESTRATION; CARDIOPULMONARY BYPASS; CORONARY ARTERY BYPASS; FEMALE; HUMANS; INTRAOPERATIVE CARE; LEUKOCYTE COUNT; MALE; MIDDLE AGED; MONITORING, INTRAOPERATIVE; NEUTROPHIL ACTIVATION; NEUTROPHILS; RESPIRATION, ARTIFICIAL;

EID: 74549134733     PISSN: 08941939     EISSN: 15210553     Source Type: Journal    
DOI: 10.1080/08941930903214776     Document Type: Article

References (14)

1. Ng CSH, Wan S, Yim APC, et al. Pulmonary dysfunction after cardiac surgery. Chest. 2002;121:1269-1277.
2. Wan S, LeClerc JL, Vincent JL. Inflammatory response to cardiopulmonary bypass: mechanisms involved and possible therapeutic strategies. Chest. 1997;112:676-692.
3. Hill GE, Alonso A, Spurzem JR, et al. Aprotinin and methylpredisolone equally blunt cardiopulmonary bypass-induced inflammation in humans. J Thorac Cardiovasc Surg. 1995;110:1658-1662.
4. SerrafA, SellakH,Herve P, et al.Vascular endothelium viability and function after total cardiopulmonary bypass in neonatal piglets. Am J Respir Crit Care Med. 1999;159:544-551.
5. Asimakopoulos G, Smith PL, Ratnatunga CP, et al. Lung injury and acute respiratory distress syndrome after cardiopulmonary bypass. Ann Thorac Surg. 1999;68:1107-1115.
6. Ng CSH, Wan S, Yim APC. Pulmonary ischemia-reperfusion injury: the Role of Apoptosis. Eur Resp J. 2005;25:356-363.
7. Wan S, Yim APC, Ng CSH, et al. Systematic organ protection in coronary artery surgery: lessons learned from off-pump practice. J Cardiac Surg. 2002;17:529-535.
8. Magnusson L, Zemgulis V, Tenling A, et al. Use of a vital capacity manoeuver to prevent atelectasis after cardiopulmonary bypass. Anesthesiology. 1998;88:134-142.
9. Magnusson L, Wicky S, Tyden H, et al. Repeated vital capacity manoeuvres after cardiopulmonary bypass effects on lung function in a Pig model. Br J Anaes. 1998;80:682-684.
10. Serraf A, Robotin M, Bonnet N, et al. Alteration of the neonatal pulmonary physiology after total cardiopulmonary bypass. J Thorac Cardiovasc Surg. 1997;114:1061-1069.
11. Keavey PM, Hasan A,AuJ, et al. The use of 99Tcm-DTPA aerosol and caesium iodide mini-scintillation detectors in the assessment of lung injury during cardiopulmonary bypass surgery. Nucl Med Commun. 1997;18:38-43.
12. Ng CSH, Arifi AA, Wan S, et al. Ventilation during cardiopulmonary bypass: impact on cytokine response and cardiopulmonary function. Ann Thorac Surg. 2008;85:154-162.
13. Friedman M, Sellke FW, Wang SY, et al. Parameters of pulmonary injury after total or partial cardiopulmonary bypass. Circulation. 1994;90:262-268.
14. Suzuki T, Fukuda T, Ito T, et al. Continuous pulmonary perfusion during cardiopulmonary bypass prevents lung injury in infants. Ann Thorac Surg. 2000;69:602-606.